–  PADCEV™ (enfortumab vedotin) plus pembrolizumab data highlight durable survival benefit in advanc

Pfizer Inc. (PFE, Financials) is retaining its quarterly dividend at 43 cents a share, sustaining on

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard

A couple of the stocks on this list pay more than 6% in dividends.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors decla

Pfizer's stock has been struggling for multiple years, and it trades at a low valuation. Its dividen

Florida files a lawsuit against Pfizer and CEO Albert Bourla over alleged deceptive vaccine marketin

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are trading as though the company's messenge

J&J's diversified portfolio, new drug launches and sales growth give it an edge despite Pfizer's che

Vaxcyte is poised to capture significant share of a $3 billion to $6 billion market following the la

Vaxcyte announced positive Phase 3 OPUS-1 trial results for its VAX-31 vaccine candidate, setting th

Eli Lilly's dominance in metabolic health through blockbuster weight-loss drugs. Pfizer's pivot towa

Ten consecutive earnings beats and a shrinking COVID hangover have Wall Street split on whether Pfiz

Energy Transfer is a midstream leader with an especially juicy distribution. Pfizer is committed to

Novo Nordisk is a leading GLP-1 company, but its portfolio beyond that is limited.  Pfizer hasn't en

Three struggling companies keep sending dividend checks while investors wait for their repairs to ki

Pfizer shares have underperformed since 2021, with the recent poor performance reflecting concerns a

There are blazing deals for some of the top healthcare stocks -- companies with proven track records

These stocks offer juicy yields and attractive risk-reward profiles.

Novo Nordisk maintains high profitability through its specialization in chronic disease management a

Pfizer Inc. (NYSE:PFE) today presented results from two Phase 3 trials evaluating the efficacy and s

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented results from two Phase 3 trials e

Pfizer has faced the challenges of declining coronavirus portfolio revenue and patent expirations in

Pfizer (PFE) closed the most recent trading day at $28.1, moving 1.47% from the previous trading ses

Kevin Warsh has stated that inflation is the Fed's primary target right now. Medtronic has a well-ab

Pfizer reports positive Phase 2 trial results for tilrekimig in treating moderate-to-severe atopic d

Turning a monthly paycheck into permanent investment income sounds straightforward until you realize

Florida Attorney General James Uthmeier on Thursday filed a lawsuit against Pfizer and its ​CEO, Alb

Buyers are stepping into Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares, evidently. The move c

LLY and Novo face off at EASD as new data fuels the GLP-1 market, while ETFs offer diversified expos

A fat dividend yield can mean a generous payout or a stock the market has already written off, and r

A 5% Treasury yield raises the bar for every dividend stock in a retirement portfolio, but four larg

Pfizer Inc. (NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented detailed results from an ongoing

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Invivyd reported Phase 3 LIBERTY trial data for VYD2311, showing strong safety and enhanced COVID-19

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Pfizer (NYSE:PFE) released second-quarter financial results and hosted an earnings call on Tuesday.

Public Citizen exposes separate government drug deals with Pfizer and Eli Lilly, warning the pacts c

European committee backs Merck's Keytruda + Padcev combo for bladder cancer after Phase 3 trial

President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Mor

But which of these two stocks offers value investors a better bang for their buck right now? We'll n

Q2/26 results, Mounjaro/Zepbound reliance, and rich valuation multiples analyzed—see why it may be o

Pfizer Inc. (NYSE:PFE) was trading at around $27 on October 5, down 1.35% on the day and up 5.18% ov

Pfizer Inc. ( PFE) announced that its Board of Directors has declared a fourth-quarter 2026 cash div

Scotiabankanalyst Louise Chen maintains $Pfizer(PFE.US)$ with a buy rating, and adjusts the target p

Vaxcyte stays a Strong Buy after VAX-31 phase 3 OPUS-1 success; broader pneumococcal coverage and 20

A couple of the stocks on this list pay more than 6% in dividends.

Novavax stock slid on Tuesday after a World Health Organization (WHO) spokesperson told reporters th